# Diarrhea - Oncology Symptom Pathway

## Objective
Manage chemotherapy-induced (CID) or radiation-induced diarrhea to prevent dehydration, electrolyte imbalance, and renal failure while ruling out infectious causes.

## Duration
**Throughout active treatment** (Acute onset or delayed)

---

## Eligibility Criteria

### Inclusion
- Patients receiving **chemotherapy** (e.g., Irinotecan, 5-FU, Capecitabine) or **pelvic radiation**
- Patients receiving **immunotherapy** (check for immune-mediated colitis)
- New onset loose stools compared to baseline

### Exclusion Criteria
- **C. difficile infection** (suspected or confirmed) - requires specific antibiotics
- **Neutropenic enterocolitis** (typhlitis) - requires surgical consult/IV antibiotics
- **Bowel obstruction** with overflow diarrhea

---

## Primary Outcome Measures

| Outcome | Timeframe | Target |
|---------|-----------|--------|
| **Symptom Control** | Daily | Return to Grade ≤1 (<4 stools/day > baseline) |
| **Hydration Status** | Daily | Maintain euvolemia |
| **Skin Integrity** | Daily | Prevent perianal skin breakdown |
| **Unplanned Utilization** | 30 days | Minimize ED visits for dehydration |

---

## Devices & Monitoring Equipment

See **[Devices Reference](../../shared/devices.md)** for detailed specifications.

### Required Devices
- **Connected Weight Scale**
  - Monitor for fluid loss
- **Thermometer**
  - Monitor for fever (infectious diarrhea/C. diff/neutropenic sepsis)

### Optional Devices
- **Connected BP Cuff**
  - Monitor for hypotension (severe dehydration)

---

## Daily Monitoring Protocol

### Clinical Team Reviews (Daily)
1. **Physiologic Data Review**
   - Weight trend
   - Temperature (Fever >38°C is a RED FLAG)

2. **Subjective Patient Data Review**
   - **Stool Frequency**: Number of stools above baseline per day
   - **Stool Consistency**: Bristol Stool Chart (Type 6-7 = diarrhea)
   - **Associated Symptoms**: Abdominal cramping, blood/mucus in stool, nausea
   - **Hydration**: Fluid intake vs output

3. **Patient Task Compliance Review**
   - Anti-diarrheal medication use (Loperamide tracking)
   - Dietary adherence (low residue/BRAT)

---

## Alert Thresholds & Escalations

See **[Universal Alert Thresholds](../../shared/alert-thresholds.md)** for complete threshold table.

### CTCAE Grading (v5.0) - Diarrhea

| Grade | Description | Clinical Significance | Action |
|-------|-------------|-----------------------|--------|
| **Grade 1** | Increase of <4 stools per day over baseline | Mild | **Advisory**: Diet modification, hydration, monitor |
| **Grade 2** | Increase of 4-6 stools per day over baseline | Moderate | **Urgent**: Start Loperamide, push fluids, assess for infection |
| **Grade 3** | Increase of ≥7 stools per day; incontinence; hospitalization indicated | Severe | **Critical**: **Hospitalization/Clinic visit** for IV fluids & evaluation |
| **Grade 4** | Life-threatening consequences; urgent intervention indicated | Life-Threatening | **Emergency**: Immediate ED transfer (shock management) |

### Symptom-Specific Red Flags
- **Bloody Stool**: Hematochezia or melena
- **Fever**: >38°C (concern for C. diff or neutropenic sepsis)
- **Severe Abdominal Pain**: Peritoneal signs (rebound/guarding)
- **Severe Dehydration**: Dizziness, syncope, hypotension
- **Immunosuppression**: Any diarrhea in neutropenic patient requires urgent evaluation

---

## Care Coordination

### Telemedicine/Virtual Visits
- **Daily check-ins** for Grade 2+ to monitor response to Loperamide
- **Urgent Video Visit** if fever or bloody stool reported

### Interdisciplinary Task Management
- **Stool Studies**: Coordinate drop-off for C. diff/culture/ova & parasites
- **Infusion**: IV fluids/electrolytes for Grade 2-3
- **Wound Care**: Management of perianal skin breakdown

---

## Treatment Protocol

### Assessment First
- Rule out infectious causes (travel, antibiotics use, sick contacts)
- Rule out overflow diarrhea (history of constipation?)
- Check medication list (laxatives, magnesium, antibiotics)

### Stepwise Management
1. **Grade 1 (Mild)**:
   - **Diet**: BRAT diet (Bananas, Rice, Applesauce, Toast), low fiber, avoid dairy/caffeine/alcohol/spicy.
   - **Hydration**: Oral rehydration solutions (Pedialyte, Gatorade).
   - **Meds**: Consider Loperamide 4mg initially, then 2mg after each loose stool (max 16mg/day).

2. **Grade 2 (Moderate)**:
   - **Meds**: High-dose Loperamide (4mg start, 2mg q2h or 4mg q4h).
   - **Add-on**: Diphenoxylate/Atropine (Lomotil) if Loperamide fails.
   - **Immunotherapy-Induced**: Consider corticosteroids (Prednisone 1-2mg/kg) if immune-mediated colitis suspected (consult oncologist).

3. **Grade 3 (Severe/Refractory)**:
   - **Meds**: Octreotide (Sandostatin) SC/IV (requires clinic/hospital).
   - **Antibiotics**: If infectious etiology confirmed (e.g., Vancomycin/Fidaxomicin for C. diff).
   - **Support**: IV fluids, electrolyte replacement.

---

## Complications to Monitor

### Dehydration / AKI
- Monitor urine output, BUN/Cr
- **Action**: IV fluids

### Electrolyte Imbalance
- Hypokalemia (arrhythmia risk), metabolic acidosis (bicarb loss)
- **Action**: Replete K+, Mg+

### Perianal Skin Breakdown
- Pain, infection risk
- **Action**: Barrier creams (zinc oxide), sitz baths, gentle cleansing

### Neutropenic Enterocolitis (Typhlitis)
- Fever + neutropenia + abdominal pain
- **Action**: **EMERGENCY** - Surgical consult, bowel rest, IV antibiotics

---

## Comorbidity Considerations

See **[Comorbidity Matrix](../../shared/comorbidity-matrix.md)** for detailed guidance.

- **Immunotherapy (Checkpoint Inhibitors)**: Diarrhea may be autoimmune colitis. **DO NOT** treat with Loperamide alone if Grade 2+. Requires steroids.
- **Irinotecan Therapy**: Early diarrhea (cholinergic) treated with Atropine. Late diarrhea treated with high-dose Loperamide.
- **Diabetes**: Infection risk higher. Monitor glucose if steroids used for colitis.
- **Ostomy**: High output stoma (>1.5L/day) requires specific management (anti-motility + hydration).

---

## Transition Criteria

### Resolution Criteria
- ✅ Stool frequency returned to Grade ≤1 (or baseline)
- ✅ Tolerating regular diet
- ✅ Hydration status stable
- ✅ No fever or abdominal pain

### References
- ASCO Guidelines for Management of Treatment-Related Symptoms
- ESMO Clinical Practice Guidelines for Diarrhea
- CTCAE v5.0
